Convenient synthesis of (4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane

被引：0
|
作者：
Jian Jiang
机构：
来源：
Chinese Chemical Letters | 2007年 / 07期
关键词：
Heptaplatin; Aminomethyl; Intermediate; Anticancer drug;
D O I：
暂无
中图分类号：
O621.3 [有机合成化学];
学科分类号：
070303 ; 081704 ;
摘要：
A convenient approach for the preparation of (4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane is described. The target compound via two steps is synthesized from diethyl-2,3-O-isobutylidene-D-tartrate, through ammonolysis and reduction.
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [1] Convenient synthesis of (4R,5R)-4,5-bis(aminomethy1)2-isopropyl-1,3-dioxolane
    Jiang, Jian
    Wang, De Cai
    Lin, Wei
    Ouyang, Ping Kai
    CHINESE CHEMICAL LETTERS, 2007, 18 (07) : 783 - 784
  • [2] Pharmacokinetics of cis-Malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) in rats
    Cho, YB
    Kim, DK
    Kim, KH
    Miyamoto, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (06): : 629 - 634
  • [3] GENERAL PHARMACOLOGY OF CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM (II)
    KIM, DK
    AHN, JS
    RYU, G
    KIM, KH
    PARK, CW
    KIM, MS
    CHUNG, MH
    SHIN, SG
    SUH, YH
    KIM, YS
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-2 (09): : 1080 - 1088
  • [4] PHARMACOKINETICS, TISSUE DISTRIBUTION, AND EXCRETION OF CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM(II) IN DOGS
    CHO, YB
    KIM, KH
    KIM, DK
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (11) : 1280 - 1285
  • [5] Mammary excretion and placental transfer of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II) in rats
    Cho, YB
    Kim, KH
    Kim, DK
    Miyamoto, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1996, 46 (09): : 926 - 930
  • [6] Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3-dioxolane]platinum(II)
    Kim, HT
    Kim, DK
    Cho, YB
    Kim, TS
    Jung, I
    Kim, KH
    Heo, DS
    Bang, YJ
    Shin, SG
    Kim, NK
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (02) : 109 - 116
  • [7] SYNTHESIS OF C-14-LABELED CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM(II) (SKI 2053R)
    KIM, DK
    KIM, Y
    RIM, J
    KIM, G
    GAM, J
    SONG, S
    YOO, K
    KIM, KH
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (02): : 157 - 164
  • [8] Pharmacokinetics of platinum following the administration of cis-(glycolato-O,O')[(4R,5R)-4,5-bis(aminomethyl) -2-isopropyl-1,3-dioxolane]platinum(II) in dogs
    Kim, DK
    Kim, HT
    Cho, YB
    Kim, TS
    Kim, KH
    Hong, WS
    ANTICANCER RESEARCH, 1997, 17 (5A) : 3681 - 3683
  • [9] ANTITUMOR-ACTIVITY OF CIS-MALONATO[(4R,5R)-4,5-BIS(AMINOMETHYL)-2-ISOPROPYL-1,3-DIOXOLANE]PLATINUM(II), A NEW PLATINUM ANALOG, AS AN ANTICANCER AGENT
    KIM, DK
    KIM, HT
    CHO, YB
    TAI, JH
    AHN, JS
    KIM, TS
    KIM, KH
    HONG, WS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (05) : 441 - 445
  • [10] Influence of exposure and infusion times on the cytotoxicity and pharmacokinetics of cis-malonato[(4R, 5R)-4,5-bis(aminomethyl)-2-isopropyl- 1,3-dioxolane]platinum(II)
    Kim H.-T.
    Kim D.-K.
    Cho Y.-B.
    Kim T.-S.
    Jung I.
    Kim K.H.
    Heo D.S.
    Bang Y.-J.
    Shin S.-G.
    Kim N.K.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (2) : 109 - 116
12345